CEO, Karolinska institutet Holding AB
Dr Lilian Wikström is the Chief Executive Officer at Karolinska Institutet Innovations AB in Stockholm Sweden.
Before her current appointment, Dr Wikström served as Head of Research and Development at NeuroNova AB. Previously at AstraZeneca she held the responsibility for the Target Discovery activities in the area of pain and central nervous system disorders as well as headed preclinical research projects.
Dr Wikström received a PhD from the Karolinska Institute and has conducted several years of pre- and postdoctoral work at the Whitehead Institute of Biomedical Research in Boston, USA, and at the Karolinska Institute. Her research focus as a Cell and Molecular Biologist has been on studying molecular mechanisms in health and disease, and on understanding the potential of applying regenerative approaches to treating diseases of the central nervous system.
During her career, Dr Wikström has published research and review papers in these topic areas, is the inventor on pending and granted patents, and serves as scientific reviewer both nationally and internationally.